The Vanguard Group, Inc. has recently announced that it has increased stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.09%. After grabbing 79.12 million shares, the institutional investor is now in possession of 0.85 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.46% having worth around $43.92 billion. Moreover, Fidelity Management & Research Co increased its share by 0.45 million to have a control over 45.97 million shares. And SSgA Funds Management, Inc. raised its holdings to 87004.0 shares by acquiring 45.96 million shares or 4.91% of the stake.
UnitedHealth Group Incorporated (UNH) concluded trading on 11/30/22 at a closing price of $547.76, with 9.68 million shares of worth about $5.3 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.21% during that period and on Wednesday the price saw a gain of about 3.74%. Currently the company’s common shares owned by public are about 935.00M shares, out of which, 929.88M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 26 analysts are covering the UNH stock and their offered price forecasts bring an average price target of $592.43. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $644.00 and could fall to a lowest price of $480.00. The stock’s current price level is 7.99% above of average price target set by the analysts, while a rise to estimated low would result in loss of -14.12% for the stock. However, touching the estimated high of $644.00 would mean a gain of 14.94% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 175 times over the past 12 months. They bought 270,007 shares in 114 of the transactions. In 61 selling transactions, insiders dumped 476,059 shares.
Vanguard Total Stock Market Index, Vanguard 500 Index Fund, and American Funds Growth Fund of Ame are the top 3 mutual funds which are holding stakes in UnitedHealth Group Incorporated Vanguard Total Stock Market Index is currently holding 28.07 million shares of worth totaling $15.58 billion. The company recently came buying 0.14 million shares which brought its stake up to 3.00% of the company’s outstanding shares. Vanguard 500 Index Fund bought 0.21 million shares, after which its hold over company’s outstanding shares expand to 2.29%, leaving 21.4 million shares with the mutual fund that have a worth of about $11.88 billion. American Funds Growth Fund of Ame, after buying 15.13 million shares, have now control over 1.62% of the stake in the company. It holds 0.22 million shares of worth $8.4 billion.
UnitedHealth Group Incorporated (NYSE: UNH) started trading at $529.72, above $1.72 from concluding price of the previous day. However, the stock later moved at a day high price of 548.08, or with a gain of 3.74%. Stock saw a price change of 4.72% in past 5 days and over the past one month there was a price change of -1.33%. Year-to-date (YTD), UNH shares are showing a performance of 9.09% which increased to 23.31% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $439.22 but also hit the highest price of $558.10 during that period. The average intraday trading volume for UnitedHealth Group Incorporated shares is 2.93 million. The stock is currently trading 3.17% above its 20-day simple moving average (SMA20), while that difference is up 4.40% for SMA50 and it goes to 6.80% higher than SMA200.
The Vanguard Group, Inc. acquired 79.12 million shares of UnitedHealth Group Incorporated having value of about $43.92 billion. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 0.85 million shares in the company valued at close to $465863854.64, or have control over 1.09% stake in the company. UnitedHealth Group Incorporated (NYSE: UNH) currently have 935.00M outstanding shares and institutions hold larger chunk of about 89.70% of that. Holding of mutual funds in the company is about 34.71% while other institutional holders and individual stake holders have control over 54.75% and 1.83% of the stake respectively.
The stock has a current market capitalization of $505.40B and its 3Y-monthly beta is at 0.74. PE ratio of stock for trailing 12 months is 26.83, while it has posted earnings per share of $20.41 in the same period. Its PEG reads 1.89 while making debt-to-equity ratio of 0.65. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for UNH, volatility over the week remained 2.03% while standing at 2.64% over the month.
Analysts are in expectations that UnitedHealth Group Incorporated (UNH) stock would likely to be making an EPS of $5.16 in the current quarter, while forecast for next quarter EPS is $6.2 and it is $24.93 for next year. For the current quarter EPS, analysts have given the company a lowest target $5.05 which is $5.3 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $4.48 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 12.80% while it is estimated to increase by 13.21% in next year. EPS is likely to shrink at an annualized rate of 14.22% for next 5-years, compared to annual growth of 20.10% made by the stock over the past 5-years.
Analysts at 26 brokerage firms have issued recommendations for the UnitedHealth Group Incorporated (UNH)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.80. Out of those 26 Wall Street analysts, 20 recommended a “Buy” rating, while 3 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on November 23, 2022 offering an Overweight rating for the stock and assigned a target price of $587 to it. Coverage by Raymond James stated UnitedHealth Group Incorporated (UNH) stock as an Outperform in their note to investors on November 21, 2022, suggesting a price target of $615 for the stock. On June 17, 2022, Loop Capital Initiated their recommendations, while on May 27, 2022, Bernstein Downgrade their ratings for the stock with a price target of $561. Stock get a Buy rating from Goldman on December 14, 2021.